Ocular Therapeutix Inc (NASDAQ:OCUL) shares popped nearly 14% yesterday, after the biopharmaceutical company announced a $10 million drug development deal with Regeneron Pharmaceuticals Inc (NASDAQ:REGN) …
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares shot up nearly 21% yesterday on back of August’s strong script data for ONIVYDE, the first approved anti-cancer treatment, …
Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) leading pipeline drug, ONIVYDE, an irinotecan liposome injection designed to treat patients suffering from metastatic pancreatic cancer, recently underperformed …
In a research report issued today, Oppenheimer’s healthcare analyst Ling Wang reiterated an Outperform rating on shares of Geron Corporation (NASDAQ:GERN) with a $5.50 …
In a research report released on Friday, Oppenheimer analyst Ling Wang reiterated an Outperform rating on shares of Rockwell Medical Inc (NASDAQ:RMTI) with a …
Rockwell Medical Inc (NASDAQ:RMTI) shares have popped 13.24% to $15.
Oppenheimer analyst Ling Wang weighed in today with a few insights on Rockwell Medical Inc (NASDAQ:RMTI), after having a meeting with CEO Robert Chioini and …
Oppenheimer analyst Ling Wang weighed in with a favorable report on shares of Rockwell Medical Inc (NASDAQ:RMTI), as the company plans to launch Triferic, a …
In a research report released April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), while no price target was …
In a research report published April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) with an Outperform …